Clinical experience with gamma knife stereotactic radiosurgery in the management of vestibular schwannomas secondary to type 2 neurofibromatosis - Wikidata - wikimedia - TriplyDB

Clinical experience with gamma knife stereotactic radiosurgery in the management of vestibular schwannomas secondary to type 2 neurofibromatosis

Clinical experience with gamma knife stereotactic radiosurgery in the management of vestibular schwannomas secondary to type 2 neurofibromatosis

http://www.wikidata.org/entity/Q30495463

about

Neurofibromatosis type 2 (NF2): a clinical and molecular review Evidence of polyclonality in neurofibromatosis type 2-associated multilobulated vestibular schwannomas Efficacy and Biomarker Study of Bevacizumab for Hearing Loss Resulting From Neurofibromatosis Type 2-Associated Vestibular Schwannomas Long-term natural history of neurofibromatosis Type 2-associated intracranial tumors Neurofibromatosis type 2.Multiple synchronous sites of origin of vestibular schwannomas in neurofibromatosis Type 2.Suggested response criteria for phase II antitumor drug studies for neurofibromatosis type 2 related vestibular schwannoma.Increased growth rate of vestibular schwannoma after resection of contralateral tumor in neurofibromatosis type 2.Radiation therapy and hearing loss Gamma knife stereotactic radiosurgery for unilateral acoustic neuromas.Stereotactic radiosurgery at St. Bartholomew's hospital: third quinquennial review.Management of the patient and family with neurofibromatosis 2: a consensus conference statement.Optimal dose of stereotactic radiosurgery for acoustic neuromas: A systematic review.Neurofibromatosis 2 [Bilateral acoustic neurofibromatosis, central neurofibromatosis, NF2, neurofibromatosis type II].Review of radiation therapy services for neurofibromatosis (NF2) patients in England.Hearing optimisation in neurofibromatosis type 2: A systematic review.Clinical outcome of neurofibromatosis type 2-related vestibular schwannoma: treatment strategies and challenges.Multifocality in neurofibromatosis type 2.Bevacizumab treatment for vestibular schwannomas in neurofibromatosis type two: report of two cases, including responses after prior gamma knife and vascular endothelial growth factor inhibition therapy.Multisession stereotactic radiosurgery for vestibular schwannomas: single-institution experience with 383 cases.Radiosurgical treatment of vestibular schwannomas in patients with neurofibromatosis type 2: tumor control and hearing preservation.Neurofibromatosis Type 2.Pathogenesis and management of type 2 neurofibromatosis Intra-Orbital Meningioma Causing Loss of Vision in Neurofibromatosis Type 2: Case Series and Management Considerations

P2860

Q21202892-984958CC-454E-4F28-BCE0-D06A925EFD1B Q30301216-8A061D38-7B7A-4071-9811-1F0F0A85F086 Q30359059-CA855DE4-2452-42F3-87B0-CD1393F34930 Q30391370-6CB517EE-618D-4786-9BEB-B3F83EC60488 Q30391375-9C0B78D5-0FB7-4341-A167-2644CA360E91 Q30405514-8ACCD037-261C-4E75-9499-3F873BBAFFFB Q30437854-FC5D22C5-8A9F-450F-BEEC-47A33DDF8B2F Q30463103-F7D81683-02E2-484D-BFE2-CD9FB55DF4C1 Q30468749-74572ED0-7A01-4C9E-A380-C7A33B339A55 Q30495461-3F47537A-AFAD-4FB5-8402-EDEF3B2C7BC9 Q30987836-88BAFEE7-1EDD-48CF-918E-E3C2325E8839 Q36251326-C99E3FF9-37CD-4BA4-AEFD-F791B21197E4 Q36586076-61BD8E35-A466-4D69-9AF9-D82D3E2E2AB0 Q37571402-6FB103D3-310D-4532-9B18-6D0EBE3633D2 Q38172274-DC81A2BE-E473-4130-B1DC-32C1D0259239 Q38858820-FA9ED2B0-E962-4E18-A92A-54E1E0BD6B4F Q39797489-B25B7506-C496-403E-BCA1-CBC1A424A6D2 Q42396670-6E4C2636-83EE-4A56-86B3-7760BBBC4C96 Q50432691-7B69816E-654E-436A-AE9E-8425FBCFC53C Q50434061-CB4B5012-89F5-45F1-9362-4EDBA9E7B8F6 Q50448171-9CBBDF1A-19DF-472E-B014-84CF9DBBEA81 Q54191697-DCD1B805-0419-4D94-9FFE-F49468849B4B Q57266478-1AB7FF00-4D43-4A56-BF1F-E56D519AB0AF Q57817149-EF6961EB-2AA6-42F4-8526-12E5A3A8E777

P2860

Clinical experience with gamma knife stereotactic radiosurgery in the management of vestibular schwannomas secondary to type 2 neurofibromatosis

http://www.wikidata.org/entity/Q30495463

description

2003 nî lūn-bûn

@nan

2003 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2003 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2003年の論文

@ja

2003年論文

@yue

2003年論文

@zh-hant

2003年論文

@zh-hk

2003年論文

@zh-mo

2003年論文

@zh-tw

2003年论文

@wuu

name

Clinical experience with gamma ...... ry to type 2 neurofibromatosis

@ast

Clinical experience with gamma ...... ry to type 2 neurofibromatosis

@en

type

label

Clinical experience with gamma ...... ry to type 2 neurofibromatosis

@ast

Clinical experience with gamma ...... ry to type 2 neurofibromatosis

@en

prefLabel

Clinical experience with gamma ...... ry to type 2 neurofibromatosis

@ast

Clinical experience with gamma ...... ry to type 2 neurofibromatosis

@en

P1433

Q30495463-8C07003C-C976-42ED-AFD2-08FAF384853A

P1476

Q30495463-2B3F6352-AEB8-462B-AADB-2DFFA2C25280

P2093

Q30495463-03E095A4-29E4-4118-980B-CA1B76AB5771

Q30495463-37F4AC0C-CD10-4054-9BBA-5FE1C4D674BC

Q30495463-40A54ED4-8544-4CD5-BEF9-4A584686263F

Q30495463-6574AA15-9B51-48D8-A409-8519FAB47B99

Q30495463-8409ED75-30C0-4360-87EE-878B940DEE01

Q30495463-AD8D6934-B689-4A74-9F2D-BD0996A3FDFD

P2860

Q30495463-07A19BE8-C676-4C38-84C1-9491AD6061B7

Q30495463-16B39DE1-8439-411D-9700-74A74BAEEBF6

Q30495463-2C735B06-8CAD-4D06-A938-F692A6F93B28

Q30495463-306022C9-3277-4A76-93E7-4B8DEC2CBAC8

Q30495463-325B54DA-09ED-427C-8372-FA60EEE2B594

Q30495463-35A50F2C-4F21-4954-BB09-F9A1F4EFCB57

Q30495463-64B925CB-9D8D-4DB0-8D50-331F53C1EAD1

Q30495463-A89308C5-4DAC-40DE-A8A8-ACE435290FE6

Q30495463-B186F1CE-F8C2-4A92-A948-937C41DA0C63

Q30495463-C566A9F7-FCD1-4FC7-960D-A041C29D89DC

P304

Q30495463-1C51DFEF-9731-4C6B-991F-4D6816852F98

P31

Q30495463-12BF8B6E-F402-49AB-A894-95C6BD9D9A8C

P356

Q30495463-AFC84107-B02D-4BFD-9FF6-7A1A99F6E57F

P407

Q30495463-26C82F86-EC1A-4FD5-9E14-BCB2667D8131

P433

Q30495463-750F26AB-6B89-4C5D-86C4-A1559AB616E2

P478

Q30495463-626E4FA0-5CCF-493D-8E9E-22FB6F647A7E

P577

Q30495463-7F8085ED-5FFA-41F3-83E6-EEAE1F655846

P5875

Q30495463-099D0089-48CD-49F3-8EA4-1D79A1661690

P698

Q30495463-6A0E19F1-FACB-49B0-8A6E-279BCF0E4632

P921

Q30495463-9EC71034-32A6-4F7A-AAF3-2989CC949237

P932

Q30495463-F96E125E-AD83-465E-A6B1-CC6F48F16226

P356

P1433

Journal of Neurology, Neurosurgery and Psychiatry

P1476

Clinical experience with gamma ...... ry to type 2 neurofibromatosis

@en

P2093

Kemeny AA

http://www.w3.org/2001/XMLSchema#string

Radatz MW

http://www.w3.org/2001/XMLSchema#string

Rodgers J

http://www.w3.org/2001/XMLSchema#string

Rowe JG

http://www.w3.org/2001/XMLSchema#string

Soanes T

http://www.w3.org/2001/XMLSchema#string

Walton L

http://www.w3.org/2001/XMLSchema#string

P2860

Malignancy in a vestibular schwannoma. Report of a case with central neurofibromatosis, treated by both stereotactic radiosurgery and surgical excision, with a review of the literature.

Interface between the facial nerve and large acoustic neurinomas. Immunohistochemical study of the cleavage plane in NF2 and non-NF2 cases.

Hearing preservation in unilateral acoustic neuroma surgery.

Tumor control after stereotactic radiosurgery in neurofibromatosis patients with bilateral acoustic tumors.

Bilateral cerebellopontine angle tumors in neurofibromatosis type 2.

Management of vestibular schwannomas (acoustic neuromas): auditory and facial nerve function after resection of 120 vestibular schwannomas in patients with neurofibromatosis 2.

Management of 1000 vestibular schwannomas (acoustic neuromas): surgical management and results with an emphasis on complications and how to avoid them.

A clinical study of vestibular schwannomas in type 2 neurofibromatosis.

Hearing restoration with auditory brainstem implants after radiosurgery for neurofibromatosis type 2.

Auditory brainstem implants: current neurosurgical experiences and perspective.

P304

1288-1293

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1136/JNNP.74.9.1288

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

74

http://www.w3.org/2001/XMLSchema#string

P577

2003-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

10601374

http://www.w3.org/2001/XMLSchema#string

P698

12933938

http://www.w3.org/2001/XMLSchema#string

P921

P932

1738689

http://www.w3.org/2001/XMLSchema#string